Emergency rooms as prevention hubs: personalized advice may improve health behaviors

NCT ID NCT07714460

First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This trial tests whether giving patients personalized prevention tips in the emergency department helps them follow through on recommended health measures, like cancer screenings and vaccines. About 658 adults visiting two ERs in France receive either tailored advice based on their age, sex, and habits, or general information. Researchers check 6-8 weeks later whether patients have taken at least a quarter of the steps recommended for them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized preventive health information
What this could lead to
If effective, this approach could turn emergency department visits into opportunities to improve public health by increasing participation in screenings and vaccinations.
What could go wrong
This is an early exploratory trial, and the effect may be small or limited to certain groups. Adherence is measured only 6-8 weeks later, so long-term impact is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier du Mans

    Le Mans, Sarthe, 72000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pôle Santé Sarthe et Loir

    La Flèche, Sarthe, 72205, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.